You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: May 17, 2025

Drugs with Dosage: GEL


✉ Email this page to a colleague

« Back to Dashboard


Drugs with Dosage: GEL

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration Dosage
Padagis Israel CLINDAMYCIN PHOSPHATE AND BENZOYL PEROXIDE benzoyl peroxide; clindamycin phosphate GEL;TOPICAL 205397-001 Sep 9, 2019 AB RX No No ⤷  Try for Free ⤷  Try for Free ⤷  Try for Free GEL;TOPICAL
Besins Hlthcare ANDROGEL testosterone GEL;TRANSDERMAL 022309-002 Sep 7, 2012 AB2 RX Yes No ⤷  Try for Free ⤷  Try for Free Y ⤷  Try for Free GEL;TRANSDERMAL
Besins Hlthcare ANDROGEL testosterone GEL;TRANSDERMAL 022309-002 Sep 7, 2012 AB2 RX Yes No ⤷  Try for Free ⤷  Try for Free ⤷  Try for Free GEL;TRANSDERMAL
Besins Hlthcare ANDROGEL testosterone GEL;TRANSDERMAL 022309-002 Sep 7, 2012 AB2 RX Yes No ⤷  Try for Free ⤷  Try for Free ⤷  Try for Free GEL;TRANSDERMAL
Besins Hlthcare ANDROGEL testosterone GEL;TRANSDERMAL 022309-002 Sep 7, 2012 AB2 RX Yes No ⤷  Try for Free ⤷  Try for Free Y ⤷  Try for Free GEL;TRANSDERMAL
Besins Hlthcare ANDROGEL testosterone GEL;TRANSDERMAL 022309-002 Sep 7, 2012 AB2 RX Yes No ⤷  Try for Free ⤷  Try for Free Y ⤷  Try for Free GEL;TRANSDERMAL
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration >Dosage

Market Dynamics and Financial Trajectory of Pharmaceutical Gels

Introduction

Pharmaceutical gels have become a significant segment in the broader pharmaceutical industry, driven by their targeted delivery capabilities, ease of use, and effectiveness in treating various conditions. This article delves into the market dynamics and financial trajectory of pharmaceutical gels, highlighting key trends, drivers, and future outlook.

Market Size and Growth

The market for semi-solid dosage forms, including gels, is experiencing robust growth. The global semi-solid dosage contract manufacturing market was valued at USD 17.57 billion in 2023 and is projected to grow at a CAGR of 11.12% from 2024 to 2030[1].

Key Drivers of Growth

Several factors are driving the growth of the pharmaceutical gel market:

Increasing Demand for Patient-Friendly Medications

There is a rising demand for medications that are easy to administer and have minimal side effects. Gels, being topical and targeted, fit this criterion perfectly, making them increasingly popular among patients and healthcare providers[1].

Growing Prevalence of Chronic Diseases

Chronic diseases such as skin conditions, arthritis, and pain management are on the rise. Gels are often preferred for treating these conditions due to their direct application to the affected area, reducing systemic exposure and side effects[1].

Technological Advancements

Advancements in formulation technologies and the use of novel excipients and absorption-enhancing ingredients are improving the efficacy and bioavailability of gel formulations. These innovations are crucial in making gels more effective and personalized[1].

Regulatory Compliance and Quality Assurance

Strict regulatory standards ensure the safety and efficacy of gel products. Compliance with these regulations, coupled with high-quality manufacturing practices, boosts market confidence and drives growth[1].

Market Segmentation

Topical Segment Dominance

The topical segment, which includes gels, ointments, and pastes, accounted for the largest revenue share of 49.50% in 2023. This dominance is due to the targeted delivery capabilities of these forms, which are widely used for treating skin conditions and other chronic diseases[1].

Regional Dynamics

North America

North America is a significant market for topical drug delivery, including gels. The region is expected to hold 36.5% of the market share in 2024, driven by the strong presence of key pharmaceutical companies, contract manufacturing organizations, and a robust research and development environment[4].

Europe and Other Regions

Europe and other regions also contribute substantially to the market. For instance, the European Union accounted for 43.4% of the consolidated revenue for companies like Servier, with a notable increase in brand-name medicine sales[2].

Financial Performance and Investment

R&D Expenditure

The increase in R&D expenditure is a critical factor driving the growth of the pharmaceutical gel market. Companies are investing heavily in developing advanced topical drug delivery systems, which includes gels. This investment is crucial for overcoming the 'translation gap' between early research and late-stage clinical development[5].

Revenue and Profitability

Companies involved in the production and distribution of pharmaceutical gels are seeing significant revenue growth. For example, Servier's brand-name medicine sales grew by 9.4% in the 2022-2023 financial year, contributing to overall revenue growth[2].

Cost-Effectiveness and Outsourcing

The cost-effectiveness of outsourcing manufacturing is another financial driver. Companies are increasingly outsourcing their manufacturing needs to contract manufacturers, which helps in reducing costs and improving efficiency[1].

Innovations and Technological Advancements

Nanotechnology and Advanced Materials

The use of nanotechnology and other advanced materials is enhancing the permeation ability, sustained release, and targeted delivery of gels. These innovations are making gels more effective and appealing to both patients and healthcare providers[4].

Personalized Medicine

The demand for personalized medicine is driving the development of customized gel formulations tailored to individual needs. This trend is expected to continue, offering more effective and convenient solutions for a wide range of conditions[1].

Regulatory Environment

Stringent Standards

Stringent regulatory standards ensure the safety and efficacy of gel products. Compliance with these regulations is crucial for market approval and consumer trust. In the U.S., for example, generic topical pharmaceutical products typically require a clinical trial program to show equivalence, unlike generic oral drugs which only require bioequivalence[3].

Market Challenges and Opportunities

Competitive Landscape

The market is characterized by a moderate level of M&A activities, innovation, and regulatory impacts. The presence of technologically advanced service providers and the rising requirement for semi-solid dosages are key factors in market growth[1].

Future Outlook

The future outlook for pharmaceutical gels is promising. With continued advancements in technology, increasing demand for patient-friendly medications, and growing prevalence of chronic diseases, the market is expected to expand significantly.

"The demand for topical solid dosage forms is expected to grow due to increasing incidences of skin conditions, the rising prevalence of chronic diseases requiring topical treatment, and advancements in drug delivery technologies."[1]

Key Takeaways

  • The global semi-solid dosage contract manufacturing market, including gels, is projected to grow at a CAGR of 11.12% from 2024 to 2030.
  • The topical segment dominates the market due to its targeted delivery capabilities.
  • Technological advancements and personalized medicine are key drivers of growth.
  • North America is a significant market for topical drug delivery, including gels.
  • Regulatory compliance and cost-effectiveness of outsourcing manufacturing are crucial factors.

FAQs

What is driving the growth of the pharmaceutical gel market?

The growth of the pharmaceutical gel market is driven by increasing demand for patient-friendly medications, growing prevalence of chronic diseases, technological advancements, and regulatory compliance.

Which region dominates the topical drug delivery market?

North America dominates the topical drug delivery market, accounting for 36.5% of the market share in 2024.

What role does R&D expenditure play in the market?

R&D expenditure is critical for developing advanced topical drug delivery systems, including gels, and for overcoming the 'translation gap' between early research and late-stage clinical development.

How are regulatory standards impacting the market?

Stringent regulatory standards ensure the safety and efficacy of gel products, boosting market confidence and driving growth.

What is the future outlook for pharmaceutical gels?

The future outlook is promising, with continued advancements in technology, increasing demand for patient-friendly medications, and growing prevalence of chronic diseases expected to expand the market significantly.

Sources

  1. Grand View Research - Semi-solid Dosage Contract Manufacturing Market Report, 2030
  2. Servier - Servier confirms its 2025 trajectory to achieve its 2030 ambition
  3. Futura Medical - Preliminary Results and R&D Summary - Futura Medical
  4. Coherent Market Insights - Topical Drug Delivery Market Size & Share Analysis - Growth Trends
  5. RAND - The Financial Ecosystem of Pharmaceutical R&D
Last updated: 2024-12-19

More… ↓

⤷  Try for Free

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.